Serum waits for India’s green signal for COVID-19 vaccine use


Serum waits for India’s green signal for COVID-19 vaccine use: Serum Institute of India, which is also manufacturing the Oxford-AstraZeneca coronavirus vaccine in India, said that it expected the government to approve the shot for emergency use in a few days.

 

The company has already made 40 million to 50 million doses of the vaccine and will be able to ramp up capacity to around 100 million a month by March when a new facility comes online.

 

"We have 40-50 million doses of Covishield stockpiled. Once we get regulatory approvals in a few days, it'll be down to the government to decide how much they can take and how fast," Serum Chief Executive Adar Poonawalla said.

 

"All data on Oxford-AstraZeneca COVID19 vaccine submitted in India and UK. There are no concerns, regulators are closely reviewing documents and data," informed Serum CEO. Poonawalla also told the reporters that India is a part of 'COVAX' and hence, the company will keep giving 50% of everything we make to India and to COVAX at the same time. However, he added that since India was a large population, the company will "probably end up giving the majority of those 50 million doses to India first."

Comments

Popular posts from this blog

N Chandrasekaran appointed chairman of Tata Sons

Visa buys NFT based CryptoPunk and paid $150,000 in Etherium

Prizm Payment Services changes its name to Hitachi Payment Services